Antibiotic X-14868A having the following chemical structure ##STR1## and the pharmaceutically acceptable salts thereof is presented. Also presented is a fermentative method of producing the above anti
The administration of the antibiotic compounds may be as a slow-pay-out bolus. Such boluses are made as tablets except that a means to delay the dissolution of the antibiotics is provided. Boluses are made to release for lengthy periods. The slow dissolution is assisted by choosing a highly ...
Homologs of antibiotic Lasalocid A and their pharmaceutically acceptable salts are produced by a known species of Streptomyces. The homologs exhibit coccidiostatic and antibacterial activity and thus
The cells were washed twice with plating medium and plated on multiwell-plates (1.5×105cells per ml) using the following defined medium: F-12/DMEM/BGJ (6:3:1) (Gibco: 430-1700/430-1600/320-2591) with 2 g BSA/l., 2.38 g Hepes/1.50 mg PSN antibiotic mixture (Gibco Laboratories),...
Over the last few years, there has been a notable interest in exploiting the antimicrobial properties of phages for the control of bacterial pathogens (phage therapy), as a strategy to curtail the relentless increase in antibiotic-resistant bacteria [2,3,4]. Moreover, phages are harmless to ...
Swiss husbandry clearly differs from other EU husbandries, because of higher standards for animal husbandry, such as lower stocking density or no lying areas on slatted floor [31]. Possible factors influencing this change of state with regard to LA-MRSA detection, like herd size and antibiotic ...